Pablo Barreiro Selected Research

Severe Acute Respiratory Syndrome

1/2021

The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Barreiro Research Topics

Disease

47	Hepatitis C 01/2023 - 01/2005
43	Chronic Hepatitis C 06/2016 - 05/2003
38	Infections 01/2023 - 02/2004
29	HIV Infections (HIV Infection) 01/2023 - 10/2002
27	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2006
15	Fibrosis (Cirrhosis) 01/2017 - 12/2004
12	Chronic Hepatitis B 01/2023 - 09/2006
12	Liver Diseases (Liver Disease) 01/2017 - 12/2004
11	COVID-19 10/2023 - 01/2020
11	Coinfection 01/2023 - 10/2005
10	Viremia 07/2017 - 07/2003
9	Hepatitis D 01/2023 - 11/2011
8	Hepatitis B 01/2023 - 05/2006
7	Virus Diseases (Viral Diseases) 12/2023 - 12/2004
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 07/2002
5	Hepatitis 01/2023 - 01/2010
5	Neoplasms (Cancer) 01/2023 - 03/2015
4	Renal Insufficiency (Renal Failure) 01/2023 - 03/2009
4	Anemia 12/2011 - 08/2005
4	End Stage Liver Disease 03/2010 - 05/2006
3	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2017
3	Disease Progression 01/2023 - 05/2018
3	Portal Hypertension 05/2010 - 01/2008
3	Hyperbilirubinemia 11/2008 - 01/2006
3	Pancreatitis 09/2006 - 05/2003
2	Human Influenza (Influenza) 12/2023 - 01/2022
2	Reinfection 01/2022 - 04/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 08/2006
2	Syphilis 01/2018 - 10/2013
2	Chronic Hepatitis (Chronic Active Hepatitis) 08/2013 - 05/2006
2	Inflammation (Inflammations) 05/2013 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2009 - 10/2002
2	Insulin Resistance 06/2008 - 04/2008
2	Hepatocellular Carcinoma (Hepatoma) 05/2006 - 12/2004
2	Lipodystrophy 07/2005 - 10/2002
1	Progeria (Hutchinson Gilford Syndrome) 01/2023
1	Poliomyelitis (Polio) 01/2022
1	Breakthrough Infections 01/2022
1	Measles 01/2022
1	Severe Acute Respiratory Syndrome 01/2021
1	Acute Generalized Exanthematous Pustulosis 09/2020

Drug/Important Bio-Agent (IBA)

45	Antiviral Agents (Antivirals)IBA 12/2023 - 03/2008
30	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 05/2003
27	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2003
26	InterferonsIBA 01/2015 - 08/2004
16	Tenofovir (Viread)FDA Link 01/2023 - 04/2006
11	VaccinesIBA 03/2022 - 09/2015
7	Didanosine (Videx)FDA LinkGeneric 05/2010 - 05/2003
6	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 05/2008
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2017 - 09/2006
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2015 - 10/2002
5	Transaminases (Aminotransferases)IBA 01/2008 - 05/2003
4	SofosbuvirIBA 01/2023 - 01/2016
4	Immunoglobulin G (IgG)IBA 03/2022 - 01/2021
4	AntigensIBA 01/2022 - 04/2007
4	Lamivudine (Epivir)FDA Link 02/2015 - 10/2007
4	Atazanavir Sulfate (Reyataz)FDA Link 07/2009 - 01/2006
3	Alanine Transaminase (SGPT)IBA 05/2013 - 04/2006
3	efavirenz (Sustiva)FDA Link 10/2007 - 07/2003
3	NucleosidesIBA 03/2007 - 07/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2020
2	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link 01/2018 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2013
2	Emtricitabine (Emtriva)FDA Link 01/2018 - 05/2008
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2017 - 03/2015
2	entecavir FDA Link 07/2017 - 05/2008
2	Hemoglobins (Hemoglobin)IBA 06/2017 - 04/2010
2	InterleukinsIBA 11/2013 - 03/2012
2	Hepatitis B e AntigensIBA 09/2013 - 04/2007
2	telaprevirIBA 01/2013 - 09/2012
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2013 - 09/2012
2	Inosine TriphosphataseIBA 03/2012 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2010 - 10/2002
2	LipidsIBA 01/2010 - 10/2002
2	Interferon-alpha (Interferon Alfa)IBA 05/2008 - 08/2005
2	Nevirapine (Viramune)FDA Link 04/2008 - 07/2003
2	EnzymesIBA 01/2008 - 12/2004
2	Zidovudine (Retrovir)FDA LinkGeneric 09/2006 - 03/2006
2	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2006 - 06/2004
1	Genetic Markers (Genetic Marker)IBA 10/2023
1	COVID-19 VaccinesIBA 10/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	lonafarnib (SCH 66336)IBA 01/2023
1	Messenger RNA (mRNA)IBA 03/2022
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 10/2021
1	Guanosine Diphosphate (GDP)IBA 01/2021

Therapy/Procedure

83	Therapeutics 01/2023 - 07/2002
13	Highly Active Antiretroviral Therapy (HAART) 03/2015 - 10/2002
3	Duration of Therapy 06/2013 - 08/2007
2	Drug Therapy (Chemotherapy) 01/2023 - 09/2015
2	Aftercare (After-Treatment) 09/2020 - 11/2006
2	Organ Transplantation 01/2020 - 09/2017
2	Art Therapy 06/2014 - 05/2013
1	Transplantation 01/2023
1	Chemoprevention 01/2022
1	Home Nursing (Nursing, Home) 01/2021